BR005-036C for migraine disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Sep 2026: Trial registered, NCT07835152

The trials

NCT07835152: Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults

State
Not started
Phase
Phase 3
People
1,000 planned
Started
20 Nov 2026
Primary completion
31 Mar 2029
Arms
BR005-036C
Results
None posted
  1. 22 Sep 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.